Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Vitronectin (VTN) (Middle Region) Peptide

VTN Reactivity: Human, Rat Host: Synthetic BP, WB
Catalog No. ABIN1540996
  • Target See all Vitronectin (VTN) products
    Vitronectin (VTN)
    Protein Region
    Middle Region
    Origin
    Human, Rat
    Source
    • 4
    Synthetic
    Application
    Blocking Peptide (BP), Western Blotting (WB)
    Sequence
    EELCSGKPFD AFTDLKNGSL FAFRGEYCYE LDETAVRPGY PKLIQDVWGI
    Characteristics
    This is a synthetic peptide designed for use in combination with anti-Vtn Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
    Purification
    Purified
  • Application Notes
    Each Investigator should determine their own optimal working dilution for specific applications.
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
    Concentration
    1 mg/mL
    Buffer
    Final peptide concentration is 1 mg/mL in PBS.
    Handling Advice
    Avoid repeated freeze-thaw cycles.
    Storage
    -20 °C
    Storage Comment
    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target
    Vitronectin (VTN)
    Background
    Vtn may act as a cofactor for plasminogen activator inhibitor 1 (PAI-1) inhibition of thrombin.

    Alias Symbols: Aa1018, MGC124961|Vn

    Protein Size: 478
    Molecular Weight
    52 kDa
    Gene ID
    29169
    NCBI Accession
    NM_019156, NP_062029
    UniProt
    Q3KR94
You are here:
Support